View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNova Cannabis 배당 및 자사주 매입배당 기준 점검 0/6Nova Cannabis 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-0.2%자사주 매입 수익률총 주주 수익률-0.2%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Oct 22SNDL Completes Privatization of Nova Cannabis and Nova Shares Expected to be Delisted from the Toronto Stock Exchange and the OTC MarketsSNDL Inc. (‘SNDL’) and Nova Cannabis Inc. (‘Nova’) announced the closing of the previously announced plan of arrangement (the ‘Arrangement’) pursuant to which SNDL has acquired all of the issued and outstanding common shares in the capital of Nova (‘Nova Shares’) not already owned by SNDL, representing approximately 34.8% of the Nova Shares. The Arrangement was approved by at least two-thirds of the holders of Nova Shares (‘Nova Shareholders’) and the majority of disinterested Nova Shareholders under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions at a special meeting of the Nova Shareholders on October 16, 2024. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. The Nova Shares are expected to be delisted from the TSX and the OTC Markets. Following the delisting of the Nova Shares, Nova intends to submit an application to cease to be a reporting issuer in each applicable jurisdiction of Canada pursuant to applicable securities laws, and, following which, SNDL intends to amalgamate with Nova pursuant to the provisions of the Business Corporations Act (Alberta). Registered holders of Nova Shares are reminded that they must send their completed and executed letter of transmittal and election form and related share certificates or DRS advices, if any, to the depository for the Arrangement, Odyssey Trust Company, as soon as possible in order to receive the Consideration to which they are entitled under the Arrangement.공시 • Aug 13Nova Shares to Be Delisted from the TSXSNDL Inc. ("SNDL") and Nova Cannabis Inc. ("Nova") announced that they have entered into an arrangement agreement (the "Agreement") pursuant to which SNDL will acquire all of the issued and outstanding common shares in the capital of Nova ("Nova Shares") not already owned by SNDL, representing approximately 34.8% of Nova Shares, by way of a statutory plan of arrangement (the "Transaction") for aggregate consideration of approximately $40 million (the "Consideration"). The Transaction has been approved by the boards of directors of both SNDL and Nova and is expected to close on or before October 18, 2024. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada.Reported Earnings • Aug 04Second quarter 2024 earnings released: EPS: CA$0.01 (vs CA$0.018 in 2Q 2023)Second quarter 2024 results: EPS: CA$0.01 (down from CA$0.018 in 2Q 2023). Revenue: CA$69.2m (up 8.1% from 2Q 2023). Net income: CA$859.0k (down 17% from 2Q 2023). Profit margin: 1.2% (down from 1.6% in 2Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 5.9% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.공시 • Jul 20Nova Cannabis Inc. to Report Q2, 2024 Results on Aug 01, 2024Nova Cannabis Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024공시 • Jul 16Nova Cannabis Inc. Announces Chief Executive Officer Changes, Effective August 1, 2024Nova Cannabis Inc. announced that Marcie Kiziak, Chief Executive Officer and a Director of Nova, will be stepping down from her role of Chief Executive Officer, effective August 1, 2024. Ms. Kiziak will continue to serve as a Director of Nova until second quarter 2024 financial results are announced. This decision comes in connection with the restructuring announced by SNDL Inc. earlier July 16, 2024. Ms. Kiziak successfully led Nova through the early years of Canadian federal legalization and worked to build a unique and highly disruptive discount strategy in Cannabis retail. Nova's success prompted a number of retail operators to follow suit, bringing greater value and convenience to consumers. Under her leadership, the Nova team has grown the Value Buds portfolio to more than 100 stores through a combination of organic and inorganic growth. Taking the reins as Interim Chief Executive Officer will be Grant Sanderson, Nova's current Chief Operating Officer. Sanderson's appointment will take effect upon Ms. Kiziak's departure.공시 • May 17Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024.New Risk • May 17New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (8.6% increase in shares outstanding). Market cap is less than US$100m (€51.6m market cap, or US$56.1m).Reported Earnings • May 09First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.01 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (in line with 1Q 2023). Revenue: CA$64.3m (up 6.8% from 1Q 2023). Net loss: CA$333.0k (loss narrowed 39% from 1Q 2023). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 5.4% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.공시 • May 01Nova Cannabis Inc. to Report Q1, 2024 Results on May 07, 2024Nova Cannabis Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024Reported Earnings • Mar 27Full year 2023 earnings released: EPS: CA$0.05 (vs CA$0.20 loss in FY 2022)Full year 2023 results: EPS: CA$0.05 (up from CA$0.20 loss in FY 2022). Revenue: CA$259.3m (up 14% from FY 2022). Net income: CA$3.03m (up CA$14.2m from FY 2022). Profit margin: 1.2% (up from net loss in FY 2022). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 6.0% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.공시 • Mar 13Nova Cannabis Inc. to Report Q4, 2023 Results on Mar 25, 2024Nova Cannabis Inc. announced that they will report Q4, 2023 results After-Market on Mar 25, 2024Reported Earnings • Nov 10Third quarter 2023 earnings released: EPS: CA$0.04 (vs CA$0.027 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.04 (up from CA$0.027 loss in 3Q 2022). Revenue: CA$67.7m (up 15% from 3Q 2022). Net income: CA$2.10m (up CA$3.63m from 3Q 2022). Profit margin: 3.1% (up from net loss in 3Q 2022).공시 • Nov 01Nova Cannabis Inc. to Report Q3, 2023 Results on Nov 08, 2023Nova Cannabis Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.024 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.02 (up from CA$0.024 loss in 2Q 2022). Revenue: CA$64.0m (up 14% from 2Q 2022). Net income: CA$1.04m (up CA$2.41m from 2Q 2022). Profit margin: 1.6% (up from net loss in 2Q 2022).공시 • Aug 04Nova Cannabis Inc. to Report Q2, 2023 Results on Aug 09, 2023Nova Cannabis Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023Reported Earnings • May 12First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.062 loss in 1Q 2022)First quarter 2023 results: CA$0.01 loss per share (improved from CA$0.062 loss in 1Q 2022). Revenue: CA$60.2m (up 21% from 1Q 2022). Net loss: CA$544.0k (loss narrowed 85% from 1Q 2022).공시 • May 05Nova Cannabis Inc. to Report Q1, 2023 Results on May 10, 2023Nova Cannabis Inc. announced that they will report Q1, 2023 results After-Market on May 10, 2023Reported Earnings • Mar 30Full year 2022 earnings released: CA$0.20 loss per share (vs CA$0.39 loss in FY 2021)Full year 2022 results: CA$0.20 loss per share (improved from CA$0.39 loss in FY 2021). Revenue: CA$226.4m (up 69% from FY 2021). Net loss: CA$11.2m (loss narrowed 46% from FY 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Specialty Retail industry in Germany.Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Ron Hozjan is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Nov 09Third quarter 2022 earnings released: CA$0.03 loss per share (vs CA$0.11 loss in 3Q 2021)Third quarter 2022 results: CA$0.03 loss per share (improved from CA$0.11 loss in 3Q 2021). Revenue: CA$58.9m (up 52% from 3Q 2021). Net loss: CA$1.54m (loss narrowed 75% from 3Q 2021). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Specialty Retail industry in Germany.Breakeven Date Change • Aug 15Forecast to breakeven in 2024The analyst covering Nova Cannabis expects the company to break even for the first time. New forecast suggests the company will make a profit of CA$2.00m in 2024. Average annual earnings growth of 89% is required to achieve expected profit on schedule.Reported Earnings • Aug 13Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: CA$56.3m (up 90% from 2Q 2021). Net loss: CA$1.37m (loss narrowed 81% from 2Q 2021). Over the next year, revenue is forecast to grow 38%, compared to a 11% growth forecast for the industry in Germany.Reported Earnings • May 11First quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.058 loss in 1Q 2021)First quarter 2022 results: CA$0.06 loss per share (down from CA$0.058 loss in 1Q 2021). Revenue: CA$49.8m (up 171% from 1Q 2021). Net loss: CA$3.53m (loss widened 59% from 1Q 2021). Over the next year, revenue is forecast to grow 91%, compared to a 12% growth forecast for the industry in Germany.Board Change • Apr 27Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Ron Hozjan is the most experienced director on the board, commencing their role in 2018. Lead Independent Director Anne Fitzgerald was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Aug 18Second quarter 2021 earnings released: CA$0.12 loss per share (vs CA$0.10 profit in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: CA$29.7m (up 86% from 2Q 2020). Net loss: CA$7.02m (down CA$8.40m from profit in 2Q 2020).지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 2LK 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 2LK 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Nova Cannabis 배당 수익률 vs 시장2LK의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (2LK)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Specialty Retail)2.6%분석가 예측 (2LK) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 2LK 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 2LK 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 2LK 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 2LK 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/10/21 04:21종가2024/10/21 00:00수익2024/06/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nova Cannabis Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Frederico Yokota Choucair GomesATB Cormark
공시 • Oct 22SNDL Completes Privatization of Nova Cannabis and Nova Shares Expected to be Delisted from the Toronto Stock Exchange and the OTC MarketsSNDL Inc. (‘SNDL’) and Nova Cannabis Inc. (‘Nova’) announced the closing of the previously announced plan of arrangement (the ‘Arrangement’) pursuant to which SNDL has acquired all of the issued and outstanding common shares in the capital of Nova (‘Nova Shares’) not already owned by SNDL, representing approximately 34.8% of the Nova Shares. The Arrangement was approved by at least two-thirds of the holders of Nova Shares (‘Nova Shareholders’) and the majority of disinterested Nova Shareholders under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions at a special meeting of the Nova Shareholders on October 16, 2024. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. The Nova Shares are expected to be delisted from the TSX and the OTC Markets. Following the delisting of the Nova Shares, Nova intends to submit an application to cease to be a reporting issuer in each applicable jurisdiction of Canada pursuant to applicable securities laws, and, following which, SNDL intends to amalgamate with Nova pursuant to the provisions of the Business Corporations Act (Alberta). Registered holders of Nova Shares are reminded that they must send their completed and executed letter of transmittal and election form and related share certificates or DRS advices, if any, to the depository for the Arrangement, Odyssey Trust Company, as soon as possible in order to receive the Consideration to which they are entitled under the Arrangement.
공시 • Aug 13Nova Shares to Be Delisted from the TSXSNDL Inc. ("SNDL") and Nova Cannabis Inc. ("Nova") announced that they have entered into an arrangement agreement (the "Agreement") pursuant to which SNDL will acquire all of the issued and outstanding common shares in the capital of Nova ("Nova Shares") not already owned by SNDL, representing approximately 34.8% of Nova Shares, by way of a statutory plan of arrangement (the "Transaction") for aggregate consideration of approximately $40 million (the "Consideration"). The Transaction has been approved by the boards of directors of both SNDL and Nova and is expected to close on or before October 18, 2024. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada.
Reported Earnings • Aug 04Second quarter 2024 earnings released: EPS: CA$0.01 (vs CA$0.018 in 2Q 2023)Second quarter 2024 results: EPS: CA$0.01 (down from CA$0.018 in 2Q 2023). Revenue: CA$69.2m (up 8.1% from 2Q 2023). Net income: CA$859.0k (down 17% from 2Q 2023). Profit margin: 1.2% (down from 1.6% in 2Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 5.9% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
공시 • Jul 20Nova Cannabis Inc. to Report Q2, 2024 Results on Aug 01, 2024Nova Cannabis Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024
공시 • Jul 16Nova Cannabis Inc. Announces Chief Executive Officer Changes, Effective August 1, 2024Nova Cannabis Inc. announced that Marcie Kiziak, Chief Executive Officer and a Director of Nova, will be stepping down from her role of Chief Executive Officer, effective August 1, 2024. Ms. Kiziak will continue to serve as a Director of Nova until second quarter 2024 financial results are announced. This decision comes in connection with the restructuring announced by SNDL Inc. earlier July 16, 2024. Ms. Kiziak successfully led Nova through the early years of Canadian federal legalization and worked to build a unique and highly disruptive discount strategy in Cannabis retail. Nova's success prompted a number of retail operators to follow suit, bringing greater value and convenience to consumers. Under her leadership, the Nova team has grown the Value Buds portfolio to more than 100 stores through a combination of organic and inorganic growth. Taking the reins as Interim Chief Executive Officer will be Grant Sanderson, Nova's current Chief Operating Officer. Sanderson's appointment will take effect upon Ms. Kiziak's departure.
공시 • May 17Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024.
New Risk • May 17New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (8.6% increase in shares outstanding). Market cap is less than US$100m (€51.6m market cap, or US$56.1m).
Reported Earnings • May 09First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.01 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (in line with 1Q 2023). Revenue: CA$64.3m (up 6.8% from 1Q 2023). Net loss: CA$333.0k (loss narrowed 39% from 1Q 2023). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 5.4% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
공시 • May 01Nova Cannabis Inc. to Report Q1, 2024 Results on May 07, 2024Nova Cannabis Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024
Reported Earnings • Mar 27Full year 2023 earnings released: EPS: CA$0.05 (vs CA$0.20 loss in FY 2022)Full year 2023 results: EPS: CA$0.05 (up from CA$0.20 loss in FY 2022). Revenue: CA$259.3m (up 14% from FY 2022). Net income: CA$3.03m (up CA$14.2m from FY 2022). Profit margin: 1.2% (up from net loss in FY 2022). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 6.0% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
공시 • Mar 13Nova Cannabis Inc. to Report Q4, 2023 Results on Mar 25, 2024Nova Cannabis Inc. announced that they will report Q4, 2023 results After-Market on Mar 25, 2024
Reported Earnings • Nov 10Third quarter 2023 earnings released: EPS: CA$0.04 (vs CA$0.027 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.04 (up from CA$0.027 loss in 3Q 2022). Revenue: CA$67.7m (up 15% from 3Q 2022). Net income: CA$2.10m (up CA$3.63m from 3Q 2022). Profit margin: 3.1% (up from net loss in 3Q 2022).
공시 • Nov 01Nova Cannabis Inc. to Report Q3, 2023 Results on Nov 08, 2023Nova Cannabis Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023
Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.024 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.02 (up from CA$0.024 loss in 2Q 2022). Revenue: CA$64.0m (up 14% from 2Q 2022). Net income: CA$1.04m (up CA$2.41m from 2Q 2022). Profit margin: 1.6% (up from net loss in 2Q 2022).
공시 • Aug 04Nova Cannabis Inc. to Report Q2, 2023 Results on Aug 09, 2023Nova Cannabis Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023
Reported Earnings • May 12First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.062 loss in 1Q 2022)First quarter 2023 results: CA$0.01 loss per share (improved from CA$0.062 loss in 1Q 2022). Revenue: CA$60.2m (up 21% from 1Q 2022). Net loss: CA$544.0k (loss narrowed 85% from 1Q 2022).
공시 • May 05Nova Cannabis Inc. to Report Q1, 2023 Results on May 10, 2023Nova Cannabis Inc. announced that they will report Q1, 2023 results After-Market on May 10, 2023
Reported Earnings • Mar 30Full year 2022 earnings released: CA$0.20 loss per share (vs CA$0.39 loss in FY 2021)Full year 2022 results: CA$0.20 loss per share (improved from CA$0.39 loss in FY 2021). Revenue: CA$226.4m (up 69% from FY 2021). Net loss: CA$11.2m (loss narrowed 46% from FY 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Specialty Retail industry in Germany.
Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Ron Hozjan is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Nov 09Third quarter 2022 earnings released: CA$0.03 loss per share (vs CA$0.11 loss in 3Q 2021)Third quarter 2022 results: CA$0.03 loss per share (improved from CA$0.11 loss in 3Q 2021). Revenue: CA$58.9m (up 52% from 3Q 2021). Net loss: CA$1.54m (loss narrowed 75% from 3Q 2021). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Specialty Retail industry in Germany.
Breakeven Date Change • Aug 15Forecast to breakeven in 2024The analyst covering Nova Cannabis expects the company to break even for the first time. New forecast suggests the company will make a profit of CA$2.00m in 2024. Average annual earnings growth of 89% is required to achieve expected profit on schedule.
Reported Earnings • Aug 13Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: CA$56.3m (up 90% from 2Q 2021). Net loss: CA$1.37m (loss narrowed 81% from 2Q 2021). Over the next year, revenue is forecast to grow 38%, compared to a 11% growth forecast for the industry in Germany.
Reported Earnings • May 11First quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.058 loss in 1Q 2021)First quarter 2022 results: CA$0.06 loss per share (down from CA$0.058 loss in 1Q 2021). Revenue: CA$49.8m (up 171% from 1Q 2021). Net loss: CA$3.53m (loss widened 59% from 1Q 2021). Over the next year, revenue is forecast to grow 91%, compared to a 12% growth forecast for the industry in Germany.
Board Change • Apr 27Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Ron Hozjan is the most experienced director on the board, commencing their role in 2018. Lead Independent Director Anne Fitzgerald was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Aug 18Second quarter 2021 earnings released: CA$0.12 loss per share (vs CA$0.10 profit in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: CA$29.7m (up 86% from 2Q 2020). Net loss: CA$7.02m (down CA$8.40m from profit in 2Q 2020).